Literature DB >> 28343541

Predicting Clinical Outcomes Using Proteomics in Non-Small Cell Lung Cancer-The Past, Present, and Future.

Ross A Soo1, Alex A Adjei2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28343541     DOI： 10.1016/j.jtho.2017.01.025

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  2 in total

1.  Cathepsin F and Fibulin-1 as novel diagnostic biomarkers for brain metastasis of non-small cell lung cancer.

Authors:  Song Wei; Wenwen Liu; Mingxin Xu; Huamin Qin; Chang Liu; Rui Zhang; Sihai Zhou; Encheng Li; Zhiyu Liu; Qi Wang
Journal:  Br J Cancer       Date:  2022-02-25       Impact factor: 9.075

2.  The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients.

Authors:  Mary Jo Fidler; Cristina L Fhied; Joanna Roder; Sanjib Basu; Selina Sayidine; Ibtihaj Fughhi; Mark Pool; Marta Batus; Philip Bonomi; Jeffrey A Borgia
Journal:  BMC Cancer       Date:  2018-03-20       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.